Effects of Ankaferd Hemostat on red blood cell aggregation: a hemorheological study

Ciftciler, Rafiye; AKSU, SALİH; Dikmenoglu Falkmarken, Neslihan; Celalettin Haznedaroglu, Ibrahim

doi:10.3906/sag-1808-60

Effects of Ankaferd Hemostat on red blood cell aggregation: a hemorheological study

Ciftciler R., AKSU S., Dikmenoglu Falkmarken N., Celalettin Haznedaroglu I.

TURKISH JOURNAL OF MEDICAL SCIENCES, cilt.49, sa.1, ss.356-360, 2019 (SCI-Expanded, Scopus, TRDizin)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 49 Sayı: 1
Basım Tarihi: 2019
Doi Numarası: 10.3906/sag-1808-60
Dergi Adı: TURKISH JOURNAL OF MEDICAL SCIENCES
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
Sayfa Sayıları: ss.356-360
Açık Arşiv Koleksiyonu: AVESİS Açık Erişim Koleksiyonu
Hacettepe Üniversitesi Adresli: Evet

Özet

Background/aim: Ankaferd hemostat (ABS; Ankaferd blood stopper, Istanbul, Turkey) is a prohemostatic agent affecting erythrocytes. The hemostatic action of ABS depends upon fibrinogen gamma chain, prothrombin, and red blood cells. The aim of this study was to assess the effects of ABS on erythrocyte aggregation via hemorheological analyses.